Interferon-gamma interrupts autocrine growth mediated by endogenous interleukin-6 in renal-cell carcinoma
- 11 November 1991
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 49 (5) , 770-773
- https://doi.org/10.1002/ijc.2910490523
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Human interleukin 6 is a direct promoter of maturation of megakaryocytes in vitro.Proceedings of the National Academy of Sciences, 1989
- Interleukin‐6 (IL‐6) functions as an in vitro autocrine growth factor in renal cell carcinomasFEBS Letters, 1989
- Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2.Proceedings of the National Academy of Sciences, 1989
- Cloning and Expression of the Human Interleukin-6 (BSF-2/IFNβ 2) ReceptorScience, 1988
- Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.Proceedings of the National Academy of Sciences, 1987
- Structure and expression of human B cell stimulatory factor-2 (BSF-2/IL-6) gene.The EMBO Journal, 1987
- Recombinant human B cell stimulatory factor 2 (BSF‐2/IFN‐β2) regulates β‐fibrinogen and albumin mRNA levels in Fao‐9 cellsFEBS Letters, 1987
- Transient accumulation of c-fos RNA following serum stimulation requires a conserved 5′ element and c-fos 3′ sequencesCell, 1985
- Expression of interleukin 2 receptors and binding of interleukin 2 by gamma interferon-induced human leukemic and normal monocytic cells.The Journal of Experimental Medicine, 1985
- RENAL CELL CARCINOMA: UNUSUAL SYSTEMIC MANIFESTATIONSMedicine, 1976